These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22832259)

  • 1. Assessing the interest to participate in a dengue vaccine efficacy trial among residents of Puerto Rico.
    Pérez-Guerra CL; Rodríguez-Acosta RL; Soto-Gómez E; Zielinski-Gutierrez E; Peña-Orellana M; Santiago LM; Rivera R; Cruz RR; Ramírez V; Tomashek KM; Dayan G
    Hum Vaccin Immunother; 2012 Jul; 8(7):905-15. PubMed ID: 22832259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community beliefs and practices about dengue in Puerto Rico.
    Pérez-Guerra CL; Zielinski-Gutierrez E; Vargas-Torres D; Clark GG
    Rev Panam Salud Publica; 2009 Mar; 25(3):218-26. PubMed ID: 19454149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in reducing dengue burden; diagnostics, control measures and vaccines.
    Lam SK
    Expert Rev Vaccines; 2013 Sep; 12(9):995-1010. PubMed ID: 24053394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comparison between the Predictors of Vaccine Uptake Intentions for Influenza and Dengue.
    Panchapakesan C; Sheldenkar A; Cayabyab YM; Ng JS; Lu J; Lwin MO
    Int J Environ Res Public Health; 2018 Nov; 15(12):. PubMed ID: 30501056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential impact of dengue vaccination: Insights from two large-scale phase III trials with a tetravalent dengue vaccine.
    Coudeville L; Baurin N; L'Azou M; Guy B
    Vaccine; 2016 Dec; 34(50):6426-6435. PubMed ID: 27601343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dengue fever: from disease to vaccination].
    Teyssou R
    Med Trop (Mars); 2009 Aug; 69(4):333-4. PubMed ID: 19725380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: randomized controlled phase I trial in the Philippines.
    Capeding RZ; Luna IA; Bomasang E; Lupisan S; Lang J; Forrat R; Wartel A; Crevat D
    Vaccine; 2011 May; 29(22):3863-72. PubMed ID: 21477675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceptability of the dengue vaccination among parents in urban poor communities of Quezon City, Philippines before and after vaccine suspension.
    Valido EM; Laksanawati IS; Utarini A
    BMC Res Notes; 2018 Sep; 11(1):661. PubMed ID: 30201034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of felt demand for dengue vaccines in the North Caribbean region of Colombia.
    Bracho-Churio YT; Martínez-Vega RA; Rodriguez-Morales AJ; Díaz-Quijano RG; Luna-González ML; Diaz-Quijano FA
    Ann Clin Microbiol Antimicrob; 2017 May; 16(1):38. PubMed ID: 28506229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dengue surveillance in preparation for field vaccine trials.
    Letson GW
    J Clin Virol; 2009 Oct; 46 Suppl 2():S10-2. PubMed ID: 19800559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tropical diseases. Dengue vaccine trial poses public health quandary.
    Normile D
    Science; 2014 Jul; 345(6195):367-8. PubMed ID: 25061184
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost-effectiveness of dengue vaccination in Puerto Rico.
    España G; Leidner AJ; Waterman SH; Perkins TA
    PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009606. PubMed ID: 34310614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of dengue DNA vaccines.
    Danko JR; Beckett CG; Porter KR
    Vaccine; 2011 Sep; 29(42):7261-6. PubMed ID: 21777640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Exploration study of knowledge and attitudes related to prevention and transmission of dengue in Puerto Rico in 2012].
    Rivera Rodríguez IJ; Puig Rivera AA; Morales-Borges RH
    Bol Asoc Med P R; 2013; 105(2):28-35. PubMed ID: 23882986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outlook for a dengue vaccine.
    Norrby R
    Clin Microbiol Infect; 2014 May; 20 Suppl 5():92-4. PubMed ID: 24438016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease.
    Hadinegoro SR; Arredondo-García JL; Capeding MR; Deseda C; Chotpitayasunondh T; Dietze R; Muhammad Ismail HI; Reynales H; Limkittikul K; Rivera-Medina DM; Tran HN; Bouckenooghe A; Chansinghakul D; Cortés M; Fanouillere K; Forrat R; Frago C; Gailhardou S; Jackson N; Noriega F; Plennevaux E; Wartel TA; Zambrano B; Saville M;
    N Engl J Med; 2015 Sep; 373(13):1195-206. PubMed ID: 26214039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DENGUE PREVENTION: CONFIRMATORY FACTOR ANALYSIS OF RELATIONSHIPS BETWEEN ECONOMIC STATUS, KNOWLEDGE, ATTITUDES AND PRACTICE, VACCINE ACCEPTANCE AND WILLINGNESS TO PARTICIPATE IN A STUDY.
    Harapan H; Bustamam A; Radiansyah A; Angraini P; Fasli R; Salwiyadi S; Bastian RA; Oktiviyari A; Akmal I; Iqbalamin M; Adil J; Henrizal F; Groneberg DA; Kuch U; Muller R
    Southeast Asian J Trop Med Public Health; 2017 Mar; 48(2):297-305. PubMed ID: 29641880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motivators and barriers influencing willingness to participate in candidate HCV vaccine trials: perspectives of people who inject drugs.
    Park JN; White B; Bates A; Enriquez J; Liao L; Maher L
    Drug Alcohol Depend; 2012 Jun; 123(1-3):35-40. PubMed ID: 22071117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current issues in dengue vaccination.
    Thomas SJ; Endy TP
    Curr Opin Infect Dis; 2013 Oct; 26(5):429-34. PubMed ID: 23963259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knowledge and attitudes in Puerto Rico concerning dengue prevention.
    Pérez-Guerra CL; Seda H; García-Rivera EJ; Clark GG
    Rev Panam Salud Publica; 2005 Apr; 17(4):243-53. PubMed ID: 15969976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.